Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/20597133 below:

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey

Affiliations

• ¹ Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.

• PMID: 20597133
• PMCID: PMC2950901
• DOI: 10.1002/cncr.25215

Item in Clipboard

Judith Swan et al. Cancer. 2010.

• ¹ Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.

• PMID: 20597133
• PMCID: PMC2950901
• DOI: 10.1002/cncr.25215

Item in Clipboard

Background: This paper examines the prevalence of cancer screening use as reported in 2005 among US adults, focusing on differences among historically underserved subgroups. We also examine trends from 1992 through 2005 to determine whether differences in screening use are increasing, staying the same, or decreasing.

Methods: Data from the National Health Interview Surveys between 1992 and 2005 were analyzed to describe patterns and trends in cancer screening practices, including Papanicolaou test, mammography, prostate-specific antigen, and colorectal screening. Logistic regression was used to report 2005 data for population subgroups defined by several demographic and socioeconomic characteristics.

Results: Rates of use for cancer tests are rising only for colorectal cancer, due largely to the increase in colorectal endoscopy screening. Use of all the modalities was strongly influenced by contact with a physician and by having health insurance coverage.

Conclusions: There remain large gaps in use for all screening modalities by education, income, usual source of care, health insurance, and recent physician contact. These specific populations would benefit from interventions to overcome these barriers to screening.

© 2010 American Cancer Society.

PubMed Disclaimer

Cancer tests among women and…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source:…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.

Cancer tests among women and…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source:…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.

Cancer tests among women and…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source:…

Cancer tests among women and men: 1992, 1998, 2000, 2003, and 2005 Source: National Health Interview Survey Predicted marginals from Model 1b. Data are adjusted for age, education, family income/poverty ratio, usual source of care, health insurance, race/ethnicity, immigration, and saw/talked to doctor past 12 months. Pap test and mammogram data are also adjusted by saw/talked to OB/GYN past 12 months.

• Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys.

  Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Breen N, et al. J Natl Cancer Inst. 2001 Nov 21;93(22):1704-13. doi: 10.1093/jnci/93.22.1704. J Natl Cancer Inst. 2001. PMID: 11717331

• Has the use of cervical, breast, and colorectal cancer screening increased in the United States?

  Anderson LM, May DS. Anderson LM, et al. Am J Public Health. 1995 Jun;85(6):840-2. doi: 10.2105/ajph.85.6.840. Am J Public Health. 1995. PMID: 7762721 Free PMC article.

• Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.

  Ruffin MT, Gorenflo DW, Woodman B. Ruffin MT, et al. J Am Board Fam Pract. 2000 Jan-Feb;13(1):1-10. doi: 10.3122/jabfm.13.1.1. J Am Board Fam Pract. 2000. PMID: 10682879 Review.

• Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

  Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Smith RA, et al. CA Cancer J Clin. 2010 Mar-Apr;60(2):99-119. doi: 10.3322/caac.20063. CA Cancer J Clin. 2010. PMID: 20228384 Review.

• Distinguishing factors for asymptomatic colonoscopy screening.

  Basch CH, Basch CE, Wolf RL, Zybert P. Basch CH, et al. J Cancer Educ. 2012 Jun;27(3):521-5. doi: 10.1007/s13187-012-0350-3. J Cancer Educ. 2012. PMID: 22477234

• Examining the association between socioeconomic status and invasive colorectal cancer incidence and mortality in California.

  Steinbrecher A, Fish K, Clarke CA, West DW, Gomez SL, Cheng I. Steinbrecher A, et al. Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1814-22. doi: 10.1158/1055-9965.EPI-12-0659. Epub 2012 Aug 21. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22911333 Free PMC article.

• Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.

  Dankner R, Boffetta P, Keinan-Boker L, Balicer RD, Berlin A, Olmer L, Murad H, Silverman B, Hoshen M, Freedman LS. Dankner R, et al. Diabetologia. 2016 Aug;59(8):1683-91. doi: 10.1007/s00125-016-3972-x. Epub 2016 May 17. Diabetologia. 2016. PMID: 27189066 Free PMC article.

• Disgusted, embarrassed, annoyed: affective associations relate to uptake of colonoscopy screening.

  Kiviniemi MT, Jandorf L, Erwin DO. Kiviniemi MT, et al. Ann Behav Med. 2014 Aug;48(1):112-9. doi: 10.1007/s12160-013-9580-9. Ann Behav Med. 2014. PMID: 24500079 Free PMC article.

• What women want: patient recommendations for improving access to breast and cervical cancer screening and follow-up.

  Ragas DM, Nonzee NJ, Tom LS, Phisuthikul AM, Luu TH, Dong X, Simon MA. Ragas DM, et al. Womens Health Issues. 2014 Sep-Oct;24(5):511-8. doi: 10.1016/j.whi.2014.06.011. Womens Health Issues. 2014. PMID: 25213744 Free PMC article.

1. 1. U.S. Department of Health and Human Services . Healthy People 2010: Understanding and Improving Health. 2nd ed. U.S. Government Printing Office; Washington, DC: 2000.
2. 1. U.S. Preventive Services Task Force . Guide to Clinical Preventive Services, Third Edition: Periodic Updates. Agency for Healthcare Research and Quality; Rockville: 2002.
3. 1. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548–552. - PubMed
4. 1. Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control. 1998;9:519–527. - PubMed
5. 1. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:636–644. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3